Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and promoter-specific chromatin binding activity. Predicted to be involved in several processes, including male meiosis I; positive regulation of DNA-templated transcription; and spermatogenesis. Predicted to be located in nucleoplasm. Predicted to be active in nucleus. Orthologous to human MYBL1 (MYB proto-oncogene like 1).
RGD Description
Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and promoter-specific chromatin binding activity. Predicted to be involved in several processes, including male meiosis I; positive regulation of DNA-templated transcription; and spermatogenesis. Predicted to act upstream of with a positive effect on siRNA-mediated retrotransposon silencing by heterochromatin formation. Predicted to be located in nucleoplasm. Predicted to be active in nucleus. Orthologous to human MYBL1 (MYB proto-oncogene like 1); PARTICIPATES IN interleukin-4 signaling pathway; INTERACTS WITH 1,2-dimethylhydrazine; 1-naphthyl isothiocyanate; 17beta-estradiol.